|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
540,054 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,092,104 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,587 |
|
|
Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 17 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-27 |
4 |
S |
$90.35 |
$90,350 |
D/D |
(1,000) |
562,203 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-26 |
4 |
OE |
$12.99 |
$90,930 |
D/D |
7,000 |
180,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-05-20 |
4 |
D |
$77.05 |
$92,614 |
D/D |
(1,202) |
473,792 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-01-18 |
4 |
AS |
$26.58 |
$93,030 |
D/D |
(3,500) |
90,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-11-30 |
4 |
AS |
$94.74 |
$94,744 |
I/I |
(1,000) |
25,758 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-09 |
4 |
S |
$48.42 |
$96,844 |
D/D |
(2,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-03 |
4 |
OE |
$6.46 |
$96,900 |
D/D |
15,000 |
32,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-12-17 |
4 |
OE |
$6.46 |
$96,900 |
D/D |
15,000 |
22,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-01-02 |
4 |
OE |
$6.46 |
$96,900 |
D/D |
15,000 |
22,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-03-09 |
4 |
OE |
$6.47 |
$97,050 |
D/D |
15,000 |
129,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-02 |
4 |
OE |
$9.86 |
$98,600 |
D/D |
10,000 |
123,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-03 |
4 |
OE |
$9.86 |
$98,600 |
D/D |
10,000 |
123,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-04 |
4 |
OE |
$9.86 |
$98,600 |
D/D |
10,000 |
123,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-04 |
4 |
AS |
$107.71 |
$98,660 |
I/I |
(916) |
42,279 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2001-04-23 |
4 |
B |
$12.00 |
$99,996 |
D/D |
8,333 |
8,333 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-03 |
4 |
S |
$25.46 |
$101,824 |
D/D |
(4,000) |
93,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-16 |
4 |
OE |
$12.99 |
$103,920 |
D/D |
8,000 |
175,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-03 |
4 |
OE |
$12.99 |
$103,920 |
I/I |
8,000 |
18,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
OE |
$12.99 |
$103,920 |
I/I |
8,000 |
28,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-03-09 |
4 |
OE |
$17.33 |
$103,980 |
D/D |
6,000 |
212,364 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-12-13 |
4 |
S |
$106.89 |
$106,890 |
D/D |
(1,000) |
320,424 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-10-25 |
4 |
OE |
$21.51 |
$107,550 |
D/D |
5,000 |
332,520 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-12-27 |
4 |
OE |
$21.51 |
$107,550 |
D/D |
5,000 |
332,530 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-05-04 |
4 |
OE |
$21.51 |
$107,550 |
D/D |
5,000 |
303,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-10-15 |
4 |
AS |
$108.24 |
$108,241 |
I/I |
(1,000) |
26,758 |
0 |
- |
|
853 Records found
|
|
Page 17 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|